Iris Acquisition p(IRAA)
Search documents
Iris Acquisition p(IRAA) - 2022 Q2 - Quarterly Report
2022-08-19 17:36
Financial Performance - The company had a net income of approximately $3,712,688 for the three months ended June 30, 2022, driven by a $4,211,660 gain on the change in fair value of warrants[109]. - For the six months ended June 30, 2022, the company reported a net income of $7,528,415, primarily due to a change in the fair value of warrants amounting to $8,605,210[111]. - The company incurred $876,623 in formation and operating costs for the six months ended June 30, 2022[111]. Cash and Capital Structure - As of June 30, 2022, the company had $50,429 in its operating bank account and negative working capital of approximately $1,395,091[113]. - The company generated gross proceeds of $276,000,000 from its IPO on March 9, 2021, selling 27,600,000 units at a price of $10.00 per unit[101]. - The company completed a private sale of 5,013,333 Private Placement Warrants at a purchase price of $1.50 per warrant, generating gross proceeds of $7,520,000[102]. - Common stock subject to possible redemption is classified as temporary equity and presented at redemption value outside of stockholders' equity[127]. Business Operations and Future Outlook - The company has not engaged in any operations or generated revenues to date, with activities focused on organizational tasks and identifying a target company for its initial business combination[108]. - The company may need to obtain additional financing to complete its initial business combination or to redeem a significant number of public shares, raising concerns about its ability to continue as a going concern[119]. - If the company is unable to complete a business combination by March 8, 2023, it will cease operations except for the purpose of liquidating[120]. Accounting and Reporting - The company had no cash flows from investing activities for the six months ended June 30, 2022, while $276,000,000 was used in net cash from investing activities in the same period of 2021[117]. - Derivative instruments, including warrants, are recorded at fair value and re-valued at each reporting date, with changes reported in the statements of operations[128]. - The allocation of proceeds from the issuance of convertible debt is guided by ASC 470-20, using the residual method to allocate IPO proceeds between Class A common stock and warrants[129]. - Management does not anticipate that recently issued accounting standards will have a material effect on the financial statements[130]. - The company qualifies as a smaller reporting company and is not required to provide certain market risk disclosures[131].
Iris Acquisition p(IRAA) - 2022 Q1 - Quarterly Report
2022-05-23 20:26
Financial Performance - The company generated a net income of approximately $3.82 million for the three months ended March 31, 2022, primarily due to a $4.39 million unrealized gain on the change in fair value of warrants[102]. - The company has not generated any operating revenues to date and will not do so until the completion of its initial Business Combination[101]. IPO and Fundraising - The company completed its IPO on March 9, 2021, raising total gross proceeds of $276 million from the sale of 27,600,000 units at a price of $10.00 per unit[98]. - The company completed a private sale of 5,013,333 Private Placement Warrants at a purchase price of $1.50 per warrant, generating gross proceeds of $7.52 million[99]. Financial Position - As of March 31, 2022, the company had $272,672 in its operating bank account and a negative working capital of $1.29 million[104]. - The company has no long-term debt or capital lease obligations as of September 30, 2021, but incurs a monthly fee of $10,000 for office space and administrative support[119]. - The company’s investments held in the Trust Account are classified as trading securities and are presented at fair value[109]. Going Concern and Business Combination - The company has incurred significant costs in pursuit of its acquisition plans, raising substantial doubt about its ability to continue as a going concern[105]. - If the company is unable to complete a Business Combination by March 8, 2023, it will cease all operations except for the purpose of liquidating[106]. Accounting Policies - The company has identified critical accounting policies that affect the reported amounts of assets, liabilities, revenues, and expenses[108].
Iris Acquisition p(IRAA) - 2021 Q4 - Annual Report
2022-04-18 20:23
IPO and Financing - The company completed its IPO on March 9, 2021, raising total gross proceeds of $276 million from the sale of 27,600,000 units at a price of $10.00 per unit[269]. - The Company raised gross proceeds of $276,000,000 from the IPO of 27,600,000 units at $10.00 per unit, which included the full exercise of the underwriters' over-allotment option[313]. - The company completed a private sale of 5,013,333 private placement warrants at a purchase price of $1.50 per warrant, generating gross proceeds of $7.52 million[270]. - The company sold 27,600,000 units at a purchase price of $10.00 per unit, generating gross proceeds of $276,000,000 during the IPO[347]. - The company issued 5,013,333 Private Warrants at a price of $1.50 per warrant, totaling $7,520,000 in a private placement[356]. - The Company must complete its initial Business Combination within 24 months from the IPO closing date, or it will cease operations and redeem public shares[319]. Financial Performance - For the year ended December 31, 2021, the company reported a net income of approximately $4.4 million, primarily due to a $7.8 million unrealized gain on the change in fair value of warrants[275]. - For the year ended December 31, 2021, the Company reported a net income of $4,369,659, compared to a net loss of $1,302 for the period from inception through December 31, 2020[302]. - The Company had a basic and diluted net income per share of $0.13 for Class A and Class B common stock for the year ended December 31, 2021[333]. - The allocation of net income for Class A common stock was $3,495,727, while for Class B it was $873,932 for the year ended December 31, 2021[333]. Assets and Liabilities - As of December 31, 2021, total assets amounted to $276,438,764, with current assets of $421,922 and investments held in the Trust Account of $276,016,842[300]. - Total liabilities as of December 31, 2021, were $21,569,899, with current liabilities of $1,380,389[300]. - The Company has an accumulated deficit of $21,131,825 as of December 31, 2021[305]. - As of December 31, 2021, the company had $336,228 in its operating bank account and negative working capital of approximately $758,467[277]. - The Company has a warrant liability valued at $10,529,510 as of December 31, 2021, subject to re-measurement at each balance sheet date[371]. - The fair value of the Private Placement Warrant liability is classified within Level 3 of the fair value hierarchy, with a value of $4,594,820 as of December 31, 2021[372]. Business Operations - The company has not generated any operating revenues to date and will not do so until the completion of its initial business combination[274]. - The Company has not commenced any operations and will not generate operating revenues until after the completion of its initial Business Combination[312]. - The company has reviewed several opportunities for a business combination but has not yet determined if it will complete any[271]. - The Company intends to complete a Business Combination before the mandatory liquidation date of March 8, 2023[324]. - If the company is unable to complete a business combination by March 8, 2023, it will cease operations except for the purpose of liquidating[279]. Costs and Expenses - The company incurred approximately $2.5 million in formation and operating costs, $0.6 million in transaction costs, and $0.3 million in excess fair value of private warrants over proceeds received for the year ended December 31, 2021[275]. - The Company incurred transaction costs for the IPO amounting to $15,627,893, of which $606,622 was included in the statements of operations[315]. - The Company recognized offering costs totaling $15,627,893, which included $5,520,000 of underwriting discount and $9,660,000 of deferred underwriting discount[334]. - The Company began paying an affiliate of the Sponsor $10,000 per month for administrative services after the IPO[364]. - The Company incurred $97,333 in administrative service fees for the year ended December 31, 2021, which are included in formation and operating costs[364]. Tax and Regulatory Matters - The company does not expect any significant changes in unrecognized tax benefits over the next twelve months[342]. - The company has identified the United States as its only major tax jurisdiction and is subject to income tax examinations by major taxing authorities since inception[342]. - The total deferred tax asset as of December 31, 2021 is $350,447, with a full valuation allowance established[377]. - The Company has $185,061 of U.S. federal net operating loss carryovers as of December 31, 2021, which do not expire[377]. Stock and Equity - The Company has authorized 280,000,000 shares of Class A common stock, with 27,600,000 shares issued and outstanding as of December 31, 2021[368]. - The Company accounts for common stock subject to possible redemption as temporary equity, presented at redemption value[332]. - The company’s common stock features certain redemption rights classified as temporary equity, presented at redemption value on the balance sheet[286]. - The weighted average shares outstanding of Class A common stock subject to possible redemption were 27,600,000, with a basic and diluted net income per share of $0.13[302]. - The company has not requested the Sponsor to reserve for indemnification obligations related to claims by third parties[321].
Iris Acquisition p(IRAA) - 2021 Q3 - Quarterly Report
2021-11-20 00:18
IPO Details - The Company completed its IPO on March 9, 2021, raising total gross proceeds of $276 million from the sale of 27,600,000 units[100]. - The Company incurred transaction costs for the IPO amounting to $15,627,893, which included $5,520,000 in underwriting discounts[103]. - The net proceeds from the IPO are held in a Trust Account and invested only in U.S. government treasury obligations or money market funds[123]. Financial Performance - For the nine months ended September 30, 2021, the Company reported a net income of approximately $4.6 million, primarily due to a $6.6 million unrealized gain on the change in fair value of warrants[107]. - As of September 30, 2021, the Company had approximately $577,871 in its operating bank account and working capital of approximately $637,029[109]. - The Company has not generated any operating revenues to date and will not do so until the completion of its initial Business Combination[106]. Business Combination - The Company has reviewed several opportunities for a Business Combination but has not yet determined if it will complete any[104]. - The Sponsor has agreed to loan the Company up to $1,141,000 to fund working capital deficiencies or transaction costs related to a Business Combination[109]. - The Company does not believe it will need to raise additional funds to meet expenditures prior to its initial Business Combination[111]. - As of September 30, 2021, the Company did not have any off-balance sheet arrangements[121].
Iris Acquisition p(IRAA) - 2021 Q2 - Quarterly Report
2021-08-16 16:03
IPO and Financial Proceeds - The Company completed its IPO on March 9, 2021, raising total gross proceeds of $276 million from the sale of 27,600,000 units[99]. - The Trust Account holds approximately $276 million, comprised of IPO proceeds and private warrant sales, which are invested in U.S. government treasury obligations[101]. - The Company incurred transaction costs of $15,627,893 related to the IPO, which included $5,520,000 in underwriting discounts[102]. Financial Performance - For the six months ended June 30, 2021, the Company reported a net loss of approximately $2.0 million, primarily due to formation and operating costs of $0.8 million and transaction costs of $0.6 million[104]. - As of June 30, 2021, the Company had approximately $692,979 in its operating bank account and working capital of approximately $882,551[106]. Operations and Revenue - The Company has not engaged in any operations or generated any revenues to date, with activities focused on preparing for the IPO and identifying a target for the initial Business Combination[103]. - The Company does not anticipate needing to raise additional funds for operating expenditures prior to the initial Business Combination[108]. Debt and Risk Management - As of June 30, 2021, the Company had no long-term debt or significant market risk exposure, with investments held in the Trust Account being short-term[117]. - The Company has not engaged in any hedging activities since inception and does not expect to do so in the future[118]. Funding and Loans - The Company has a loan agreement with the Sponsor for up to $1,141,000 to fund working capital deficiencies or transaction costs related to a Business Combination[106].
Iris Acquisition p(IRAA) - 2021 Q1 - Quarterly Report
2021-07-22 21:28
Financial Performance - For the three months ended March 31, 2021, the Company reported a net loss of approximately $2.0 million, which included $0.4 million in formation and operating costs and $0.7 million in unrealized losses on warrants[117]. - The Company has not engaged in any operations or generated any revenues to date, with activities focused on organizational tasks and identifying a target for the initial Business Combination[116]. Capital Structure - The Company completed its IPO on March 9, 2021, raising total gross proceeds of $276 million from the sale of 27,600,000 units[112]. - The Company has placed $276 million in a U.S.-based trust account, which includes $268.48 million from the IPO and $7.52 million from the private sale of warrants[114]. - As of March 31, 2021, the Company had approximately $1.0 million in its operating bank account and working capital of approximately $1.2 million[118]. Financing Needs - The Company may need to obtain additional financing to complete a Business Combination or if a significant number of public shares are redeemed[120]. - The Company believes it will have sufficient working capital and borrowing capacity to meet its needs through the earlier of the consummation of a Business Combination or one year from the filing date[119]. Operational Costs - The Company incurred a monthly fee of $10,000 for office space and administrative support, which began on November 5, 2020[129]. - The Company has no long-term debt or significant market risk as of March 31, 2021, with investments held in the Trust Account limited to U.S. government treasury obligations[130]. Risk Management - The Company has not engaged in any hedging activities since inception and does not expect to do so in the future[131].